| Literature DB >> 35498908 |
Jianju Li1, Jing Liu1,2, Hang Yu1, Weixin Zhao1, Xinhui Xia1, Shijie You1, Jun Zhang1, Hailong Tong1,3, Liangliang Wei1.
Abstract
The ongoing coronavirus pandemic (COVID-19) throughout the world has severely threatened the global economy and public health. Due to receiving severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a wide variety of sources (e.g., households, hospitals, slaughterhouses), urban sewage treatment systems are regarded as an important path for the transmission of waterborne viruses. This review presents a quantitative profile of the concentration distribution of typical viruses within wastewater collection systems and evaluates the influence of different characteristics of sewer systems on virus species and concentration. Then, the efficiencies and mechanisms of virus removal in the units of wastewater treatment plants (WWTPs) are summarized and compared, among which the inactivation efficiencies of typical viruses by typical disinfection approaches under varied operational conditions are elucidated. Subsequently, the occurrence and removal of viruses in treated effluent reuse and desalination, as well as that in sewage sludge treatment, are discussed. Potential dissemination of viruses is emphasized by occurrence via aerosolization from toilets, the collection system and WWTP aeration, which might have a vital role in the transmission and spread of viruses. Finally, the frequency and concentration of viruses in reclaimed water, the probability of infection are also reviewed for discussing the potential health risks.Entities:
Keywords: Collection systems; Fate; Removal; Virus; WWTP treatment units
Year: 2022 PMID: 35498908 PMCID: PMC9033450 DOI: 10.1016/j.desal.2022.115798
Source DB: PubMed Journal: Desalination ISSN: 0011-9164 Impact factor: 11.211
Virus concentrations in sewage from different sources.
| Virus | Characteristics | Symptoms and diseases | Viral load at patients feces | Virus concentration in slaughterhouses | Virus concentration in hospital wastewater |
|---|---|---|---|---|---|
| Nov | 27–35 nm; non-enveloped, spherical, non-segmented, positive-sense, ssRNA virus | Diarrhea, vomiting, nausea, dehydration, fever, abdominal pain, gastroenteritis | 2.5 × 106–3.9 × 109 genome copies·g−1 | NoV were not detected | 3.6 × 102, 3.1 × 102 genome copies·mL−1 |
| RoV | 70 nm; non-enveloped, icosahedral, segmented, positive-sense dsRNA virus | Diarrhea, gastroenteritis | 1010 genome copies·g−1 | GARV: 0.8% | 1.7 × 103, 4.1 × 106 genome copies·mL−1 |
| HAV | 27–34 nm; non-enveloped, icosahedral, non-segmented, positive-sense ssRNA virus | Inflammation of the liver which causes severe pain, fever, vomiting, incapacitation of the patient | / | / | 2.1 × 104 genome copies·mL−1 |
| HEV | 27–34 nm; non-enveloped, spherical, non-segmented, positive-sense, ssRNA | Non-bacterial gastroenteritis in humans | 2.1 × 104–7.7 × 107 genome copies·g−1 | 1.3 × 10−1–6.4 × 103 genome copies·mL−1 | 55.6% |
| AdV | 60–90 nm; non-enveloped, icosahedral, non-segmented, dsDNA virus | Gastroenteritis, conjunctivitis, respiratory disease | PAdV: 1.56 × 103 genome copies·mL−1 | 5.0 × 103, 1.0 × 103 genome copies·mL−1 | |
| SARS-CoV | 60–200 nm; enveloped, spherical, non-segmented, positive-sense, ssRNA virus | Respiratory and enteric symptoms | 105.6–108.1 genome copies·g−1 | / | 0.633 genome copies·mL−1 in wastewater of the adjusting tank |
| PyVs | 40–50 nm; non-enveloped, icosahedral, non-segmented dsDNA virus | Sarcoma, cancer | / | OPyV: 9.81 × 10−1 genome copies·mL−1 | 45.0% |
| AV | 27–32 nm; non-enveloped, spherical, non-segmented, positive-sense, ssRNA virus | Gastroenteritis | 2.8 × 105–1.6 × 1011 genome copies·mL−1 | 20.8% | 11.7% of the children stool samples with a diagnosis of gastroenteritis |
| CV | 20-30 nm; non-enveloped, icosahedral, non-segmented, positive-sense, ssRNA | Meningitis, respiratory disease | Ct value: 21.9–38.4 | 25 × 105 genome copies·mL−1 in CA6-infected children stool | |
| PV | 20–30 nm; non-enveloped, icosahedral, non-segmented, positive-sense, ssRNA virus | Fever, paralysis, meningitis, poliomyelitis | 4.7 × 102–2.1 × 105 genome copies·g−1 | 0.61% of pediatric patients stool | |
| SaVs | 41–46 nm; non-enveloped, icosahedral, non-segmented, positive-sense, ssRNA virus | Dehydration, vomiting, abdominal pain | 3.46 × 105–2.09 × 1010 genome copies·g−1 | GIII SaVs:78% | 29.4% |
Notes: NoV, norovirus; RoV, rotavirus; HAV, hepatitis A virus; HEV, hepatitis E virus; AdV, adenovirus; SARS-CoV, severe acute respiratory syndrome coronavirus; PyVs, polyomavirus; AV, astrovirus; CV, coxsackievirus; PV, poliovirus; SaVs, sapovirus; dsRNA, double-stranded RNA; ssRNA, single-stranded RNA; dsDNA, double-stranded DNA; NoV GII, norovirus GII; GARV, group A rotavirus; PAdV, Porcine adenovirus; OPyV, Ovine polyomavirus; Ct, Cycle threshold.
Fig. 1Persistence of typical virus in wastewater at varying temperature [57], [58], [59], [60], [61].
(SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; SARS-CoV, severe acute respiratory syndrome coronavirus; MNV, Murine Norovirus; MHV, Mouse hepatitis virus; AdV, adenovirus; PV, poliovirus)
Concentration of the typical viruses in the collection system (per liter).
| Virus | Raw domestic wastewater | Influent of septic tank | Combined sewer system | WWTPs influent |
|---|---|---|---|---|
| EV | 104–105 | 10–102 | 6 × 103–1.74 × 105 | 3 × 102–1.1 × 106 |
| RoV | 2 × 102–103 | 10–102 | / | 106–8.9 × 106 |
| AdV | / | / | 5.3 × 103 | 2 × 104–6.7 × 108 |
| NoV | 2 × 105 | 105 | 2.3 × 103 | 5.6 × 102–8.3 × 103 |
| 6.31 × 105–1.61 × 106 | 5.5 × 105–6 × 106 |
Notes: EV, enterovirus; RoV, rotavirus; AdV, adenovirus; Nov, norovirus.
Fig. 2Mechanism and log removal efficiency of different viruses during different WWTP units operation [69], [73], [104], [108], [121], [122], [123], [124], [125], [126], [127], [128], [129]. (SARS-CoV-2, severe acute respiratory syndrome coronavirus2; PyVs, polyomavirus; RoV, rotavirus; NoV GII, norovirus GII; NoV GI, norovirus GI; EV, enterovirus; AdV, adenovirus; HTtV, human torque teno virus; HPyV, Human polyomavirus; PLVs, primate lentivirus; AV, astrovirus; SaV, sapovirus).
Relative sensitivity of enteric viruses to chlorine, chlorine dioxide, and ozonation disinfections [15].
| Chlorine | Chlorine dioxide | Ozonation | |
|---|---|---|---|
| HRoV | L | L | L |
| f2 | L | M | H |
| CV | M | L | H |
| Echo | M | L | H |
| PV | H | M | L |
| SA11 | H | H | L |
Note: HRoV, Human rotavirus; CV, coxsackievirus; Echo, echovirus; PV, poliovirus; SA11, simian rotavirus; H: high, M: middle, L: light.
Inactivation efficiency, operational parameters of the typical disinfectants for different viruses inactivation.
| Viruses | UV | Ozonation | Chlorine dioxide | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dosage (mJ·cm−1) | Removal | Ref. | Parameters | Ozone | Contact time | Removal | Ref. | Concentration | Treatment time | Removal | Ref. | |
| PV-1 | 30 | 3.0 log | 5 °C pH 7 | 0.37 mg·L−1 | 5 min | 4.5 log | 85 μM | 1 min | 4.0 log | |||
| 9 | 2.0 log | |||||||||||
| 18 | 3.43 log | |||||||||||
| 24 | 4.75 log | |||||||||||
| 35 | 5.7 log | |||||||||||
| Ad 40 | 9 | 0.2 log | 5 °C pH 7 | 0.60 mg·L−1·min | / | 4.0 log | 15 °C, pH 6 | 4.0 log | ||||
| 18 | 0.68 log | |||||||||||
| 24 | 0.87 log | |||||||||||
| 35 | 1.21 log | 15 °C, pH 8 | 4.0 log | |||||||||
| 90 | 3.0 log | |||||||||||
| 120 | 4.0 log | |||||||||||
| Ad 2 | 78 | 2.0 log | 5.1 × 10−6-4.1 × 10−3 mg·min·L−1 | 2.0 log | 1.0 ppm | 15 s | 1.5 log | |||||
| 119 | 3.0 log | |||||||||||
| 160 | 4.0 log | 10 ppm | 15 s | 5.0 log | ||||||||
| 30 (medium-pressure) | 2.19 log | 0.7–0.9 mg·min·L−1 | 3.0 log | |||||||||
| 100 ppm | 15 s | >6.0 log | ||||||||||
| 90 (medium-pressure) | 5.36 log | 0.77–1.10 mg·min·L−1 | 4.0 log | |||||||||
| Simian Rotavirus (SA11) | 42 | 4.0 log | 4 °C pH 6 | 0.17 mg·L−1 | 8 s | 4.0 log | 0.5 mg·L−1; pH 10 | 15 s | >4.0 log | |||
| 4 °C pH 7 | 0.1 mg·L−1 | 32 s | 4.0log | |||||||||
| 4 °C pH 8 | 0.1 mg·L−1 | 6 s | 4.0 log | |||||||||
| FCV | 36 | 4.0 log | 5 °C pH 7 0.07 | 0.01–0.03 mg·L−1 min | 4.0 log | 0.8 mg·L−1 | 2.1 min | 4.0 log | ||||
| 0.2 mg·L−1 | 19.5 min | 4.0 log | ||||||||||
| HAV | 16 | 4.0 log | pH 7.0, | 1.0 mg·L−1 | 24 s | 4 log | 0.8 mg·L−1 | 0.43 min | 4.0 log | |||
| 0.4 mg·L−1 | 19.58 min | 4.0 log | ||||||||||
| CVB5 | 27 | 3.0 log | 1.0 × 10−5–8.0 × 10−3 mg·min·L−1 | 2.0 log | 0.6 mg·L−1 | 1.00 min | 4.0 log | |||||
| 36 | 4.0 log | 0.4 mg·L−1 | 2.41 min | 4.0 log | ||||||||
| 29 | 4.0 log | 0.2 mg·L−1 | 3.73 min | 4.0 log | ||||||||
| SARS-CoV | 3.75 | 0.9 log | / | / | / | 10 mg·L−1 | 1 min | 0.25 log | ||||
| 37.5 | 3.1 log | 5 min | 0.5 log | |||||||||
| 75 | >3.3 log | 10 min | >6.0 log | |||||||||
| 112.5 | >3.3 log | 20 min | >6.0 log | |||||||||
| 225 | >3.3 log | 40 mg·L−1 | 1 min | 1.25log | ||||||||
| 292 | 1.0 log | 5 min | >6.0 log | |||||||||
| 1048 | >4.0 log | 10 min | >6.0 log | |||||||||
Note: PV-1, poliovirus 1; Ad 40, adenovirus type 40; Ad 2, adenovirus type 2; FCV, feline calicivirus; HAV, hepatitis A virus; CVB5, coxsackievirus B5; SARS-CoV, severe acute respiratory syndrome coronavirus.
Fig. 3Concentration and positive detection rates of typical viruses in WWTP effluent of (a) American Continent [7], [129], [172], [173], [174], [175], [176], (b) Europe [177], [178], [179], [180], [181], (c) Asia [182], [183], [184], [185], [186], [187], [188], [189], [190], (d) Africa [191], [192], [193], [194], [195]. (EVs, enterovirus; HAV, hepatitis A virus; HAdV, human adenovirus; JCPyV, JC Polyomavirus; NoV GII, norovirus GII; NoV GI, norovirus GI; RoV, rotavirus; RV-A, rotavirus A; SaVs, sapovirus; HAstV, Human astrovirus; HEV, hepatitis E virus; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; AdV, adenovirus; AiVs, Avian influenza virus; HBoV, Human bocavirus; HPV, Human papillomavirus; HPyV, human polyomavirus; NoV, norovirus).
Concentration of typical viruses in sewage sludge samples.
| Virus | Raw sludge (genome copies·kg−1) | Anaerobically digested sludge (genome copies·kg−1) | References |
|---|---|---|---|
| EV | 105−107 | 2 × 102–2.1 × 105 | |
| NoV GI | / | 5.0 × 107 | |
| Nov GII | 1.6 × 104–4.90 × 105 | 1.50 × 108 | |
| RoV | 8.00 × 103–8.00 × 105 | 1.4 × 104–4.85 × 105 | |
| HAdV | 1.80 × 105–1.20 × 1010 | 9.10 × 107–6.90 × 109 | |
| HAV | Activated sludge: | / | |
| AdV | Activated sludge: | / | |
| EV | 5.47 × 107–1.15 × 108 | 2.60 × 107–7.60 × 107 | |
| HPyV | / | 7.40 × 107–2.5 × 108 | |
| Parechovirus | / | 2.51 × 107–2.51 × 108 | |
| SARS-CoV-2 | 1.17 × 104–4.02 × 104 | 8.13 × 101–8.13 × 104 |
Note: EV, enterovirus; NoV GI, norovirus GI; NoV GII, norovirus GII; RoV, rotavirus; HAdV, human adenovirus; HAV, hepatitis A virus; AdV, adenovirus; HPyV, human polyomavirus; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Expressed in genome copies·L−1.
Fig. 4Dissemination of virus via aerosol route in the whole process of sewage collection, transmission and treatment [252], [253], [254], [255].
(a) Concentrations of MS2 and Phi6 in aerosols generated in lab-scale models of toilet and converging sewer pipes. (b) Concentrations of typical viruses in aerosols generated from different units of WWTP. (c) Overview of potential virus dissemination via aerosol route during wastewater collection, transmission and treatment. (Different font colors in (a) and column colors in (b) indicate that the data come from different articles)
(RoV, rotavirus; AdV, adenovirus; NoV GII, norovirus GII; HAV, hepatitis A virus; NoV GI, norovirus GI.)